Abstract:Nanobodies, the smallest functional antibody fragment derived from camelid heavy-chain-only antibodies, have emerged as powerful tools for diverse biomedical applications. In this comprehensive review, we discuss the structural characteristics, functional properties, and computational approaches driving the design and optimisation of synthetic nanobodies. We explore their unique antigen-binding domains, highlighting the critical role of complementarity-determining regions in target recognition and specificity. This review further underscores the advantages of nanobodies over conventional antibodies from a biosynthesis perspective, including their small size, stability, and solubility, which make them ideal candidates for economical antigen capture in diagnostics, therapeutics, and biosensing. We discuss the recent advancements in computational methods for nanobody modelling, epitope prediction, and affinity maturation, shedding light on their intricate antigen-binding mechanisms and conformational dynamics. Finally, we examine a direct example of how computational design strategies were implemented for improving a nanobody-based immunosensor, known as a Quenchbody. Through combining experimental findings and computational insights, this review elucidates the transformative impact of nanobodies in biotechnology and biomedical research, offering a roadmap for future advancements and applications in healthcare and diagnostics.

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on the design and optimization of Nanobodies, specifically including the following aspects: 1. **Structural Characteristics and Functional Properties**: The paper explores the unique antigen - binding domains of Nanobodies, especially the crucial role of Complementarity - Determining Regions (CDRs) in target recognition and specificity. Nanobodies are the smallest functional antibody fragments extracted from the heavy - chain antibodies of camelids. They have unique structural features, which make them perform excellently in a variety of biomedical applications. 2. **Development of Computational Methods**: The paper discusses in detail the latest progress in Nanobody modeling, epitope prediction, and affinity maturation. These computational methods are essential for understanding the antigen - binding mechanism of Nanobodies and their conformational dynamics. Through techniques such as Molecular Dynamics Simulations (MD), Machine Learning (ML), and Artificial Intelligence (AI), researchers can explore the dynamic behavior and structural stability of Nanobodies more in - depth. 3. **Biosynthetic Advantages**: Compared with traditional antibodies, Nanobodies have obvious advantages in biosynthesis, such as small size, high stability, and solubility. These characteristics make Nanobodies cost - effective antigen - capture candidates, suitable for fields such as diagnosis, treatment, and biosensing. 4. **Practical Application Cases**: The paper also provides a specific example, showing how to improve the Nanobody - based immunosensor (Quenchbody) through computational design strategies. Combining experimental data and computational insights, this case demonstrates the effectiveness of computational methods in optimizing Nanobody performance. 5. **Future Development Directions**: Finally, the paper looks forward to the transformative impact of Nanobodies in biotechnology and biomedical research and provides a roadmap for future progress and applications. By integrating experimental findings and computational insights, researchers hope to further promote the application of Nanobodies in the healthcare and diagnosis fields. In summary, this paper aims to provide a theoretical basis and technical support for the design and optimization of Nanobodies by comprehensively reviewing the latest progress in their structural characteristics, functional properties, and computational methods, thereby promoting their wide application in the biomedical field.

Nanobody Engineering: Computational Modelling and Design for Biomedical and Therapeutic Applications

Nanobody Engineering: Computational Modelling and Design for Biomedical and Therapeutic Applications

Characterization of a nanobody-epitope tag interaction and its application for receptor engineering

Nanobody Technology: A Versatile Toolkit for Microscopic Imaging, Protein–Protein Interaction Analysis, and Protein Function Exploration

Advancements in nanobody generation: Integrating conventional, in silico, and machine learning approaches

Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics

Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of Cancer

Nanobody: a promising toolkit for molecular imaging and disease therapy

A new generation of nanobody research tools using improved mass spectrometry-based discovery methods

Nanobodies in the fight against infectious diseases: repurposing nature's tiny weapons

Design of Nanobody-based Bispecific Constructs by in silico Affinity Maturation and Umbrella Sampling Simulations

Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years

Prospects for the computational humanization of antibodies and nanobodies

Nanobody Conjugates for Targeted Cancer Therapy and Imaging

Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy

[Application of nanobody in cancer treatment].

Structural Modeling of Nanobodies: A Benchmark of State-of-the-Art Artificial Intelligence Programs

Nanobodies: a promising approach to treatment of viral diseases

Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy

Engineered Nanobodies Elicit Durable and Robust Bi‐Therapeutic Efficacy Toward Virus and Tumors